Latest filing published 27 Mar 2018 for CanniMed Therapeutics Inc., €59.2M.
No signal scores available.
Aurora Cannabis Inc. is a declared insider of CanniMed Therapeutics Inc., with filings sourced from SEDI. Over a trading history stretching from 15 March 2018 to 26 March 2018, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 27 March 2018: a transaction of €59.2M, in CanniMed Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations